ATE427355T1 - Menschliche alpha2-delta4-calciumkanal- untereinheit codierende cdna - Google Patents
Menschliche alpha2-delta4-calciumkanal- untereinheit codierende cdnaInfo
- Publication number
- ATE427355T1 ATE427355T1 AT02728726T AT02728726T ATE427355T1 AT E427355 T1 ATE427355 T1 AT E427355T1 AT 02728726 T AT02728726 T AT 02728726T AT 02728726 T AT02728726 T AT 02728726T AT E427355 T1 ATE427355 T1 AT E427355T1
- Authority
- AT
- Austria
- Prior art keywords
- calcium channel
- delta4
- channel subunit
- subunit coding
- coding cdna
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychiatry (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Addiction (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Compression, Expansion, Code Conversion, And Decoders (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/833,222 US7524643B2 (en) | 2001-04-11 | 2001-04-11 | CDNA encoding the human alpha2 delta4 calcium channel subunit |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE427355T1 true ATE427355T1 (de) | 2009-04-15 |
Family
ID=25263783
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02728726T ATE427355T1 (de) | 2001-04-11 | 2002-04-10 | Menschliche alpha2-delta4-calciumkanal- untereinheit codierende cdna |
Country Status (9)
Country | Link |
---|---|
US (3) | US7524643B2 (de) |
EP (1) | EP1427825B8 (de) |
JP (1) | JP2005503771A (de) |
AT (1) | ATE427355T1 (de) |
AU (1) | AU2002258760B2 (de) |
DE (1) | DE60231816D1 (de) |
ES (1) | ES2323946T3 (de) |
HK (1) | HK1065067A1 (de) |
WO (1) | WO2002083847A2 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8512971B2 (en) * | 2002-12-10 | 2013-08-20 | Echelon Biosciences, Inc. | Compounds and methods of use thereof for assaying lysophospholipase D activity |
CN1919868B (zh) * | 2005-08-26 | 2011-09-21 | 中国科学院上海生命科学研究院 | 慢性神经痛相关蛋白及其基因 |
WO2014110628A1 (en) * | 2013-01-18 | 2014-07-24 | Itek Ventures Pty Ltd | Gene and mutations thereof associated with seizure disorders |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE139542T1 (de) | 1988-04-04 | 1996-07-15 | Salk Inst Biotech Ind | Calciumkanal-zusammensetzungen und verfahren |
US5712158A (en) | 1995-06-06 | 1998-01-27 | Warner-Lambert Company | Cell line for the rapid expression of functional calcium channels |
JP2002526100A (ja) | 1998-10-07 | 2002-08-20 | ワーナー−ランバート・カンパニー | アルファ−2/デルタ遺伝子 |
JP2004500034A (ja) | 1999-07-28 | 2004-01-08 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | カルシウムチャネル輸送ポリヌクレオチド、ペプチドおよび抗体 |
US6783952B1 (en) * | 1999-09-16 | 2004-08-31 | Warner-Lambert Company | Secreted soluble α2δ-2, α2δ-3 or α2δ-4 calcium channel subunit polypeptides and screening assays using same |
-
2001
- 2001-04-11 US US09/833,222 patent/US7524643B2/en not_active Expired - Fee Related
-
2002
- 2002-04-10 DE DE60231816T patent/DE60231816D1/de not_active Expired - Lifetime
- 2002-04-10 JP JP2002582186A patent/JP2005503771A/ja active Pending
- 2002-04-10 EP EP02728726A patent/EP1427825B8/de not_active Expired - Lifetime
- 2002-04-10 AT AT02728726T patent/ATE427355T1/de not_active IP Right Cessation
- 2002-04-10 ES ES02728726T patent/ES2323946T3/es not_active Expired - Lifetime
- 2002-04-10 AU AU2002258760A patent/AU2002258760B2/en not_active Ceased
- 2002-04-10 US US10/119,624 patent/US7157248B2/en not_active Expired - Fee Related
- 2002-04-10 WO PCT/US2002/011297 patent/WO2002083847A2/en active IP Right Grant
-
2004
- 2004-10-13 HK HK04107875.1A patent/HK1065067A1/xx not_active IP Right Cessation
-
2009
- 2009-03-20 US US12/408,407 patent/US7820792B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2002083847A2 (en) | 2002-10-24 |
JP2005503771A (ja) | 2005-02-10 |
WO2002083847A3 (en) | 2004-04-01 |
EP1427825A4 (de) | 2005-03-16 |
US7524643B2 (en) | 2009-04-28 |
EP1427825B8 (de) | 2009-06-17 |
DE60231816D1 (de) | 2009-05-14 |
US20030166045A1 (en) | 2003-09-04 |
EP1427825A2 (de) | 2004-06-16 |
US20090259022A1 (en) | 2009-10-15 |
HK1065067A1 (en) | 2005-02-08 |
ES2323946T3 (es) | 2009-07-28 |
AU2002258760B2 (en) | 2007-08-09 |
EP1427825B1 (de) | 2009-04-01 |
US20030170785A1 (en) | 2003-09-11 |
US7157248B2 (en) | 2007-01-02 |
US7820792B2 (en) | 2010-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE182901T1 (de) | Für androgen-rezeptor-protein kodierende dna | |
TR200100056T2 (tr) | Nörotrofik faktörler | |
DE50112802D1 (de) | Peptide, deren herstellung und verwendung zur bindung von immunglobulinen | |
DE60325892D1 (de) | Stellungs- und verwendungsverfahren | |
MXPA03002218A (es) | Peptidos antimicrobianos y metodos de uso. | |
EA199900355A1 (ru) | Теломераза обратная тринскриптаза | |
RS50364B (sr) | Modifikovani faktor viii | |
DE59903410D1 (de) | Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung | |
WO2002006316A3 (en) | Alpha-msh related compounds and methods of use | |
WO2009001260A3 (en) | Cosmetic use of apolipoprotein d type proteins | |
WO2002050111A3 (en) | Isolated laminin 10 | |
ATE427355T1 (de) | Menschliche alpha2-delta4-calciumkanal- untereinheit codierende cdna | |
ATE550345T1 (de) | Sfrp, mit sfrp-interagierende peptidmotive sowie verwendungsverfahren | |
WO2008068428A3 (fr) | Utilisation cosmétique de protéines de type chitinase | |
WO2000000506A3 (en) | Human proteins having hydrophobic domains and dnas encoding these proteins | |
ATE230027T1 (de) | Menschliche dnase i varianten | |
DE60031390D1 (de) | Nukleinsäure, die für polypeptide kodieren die eine mutt-domäne enthalten | |
AU4956901A (en) | Novel human 7tm proteins and polynucleotides encoding the same | |
DE60120187D1 (de) | Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen | |
WO2002012475A3 (en) | C1q-related factor, homologous polypeptides and therapeutic uses thereof | |
WO2002036633A3 (en) | Human 7tm proteins and polynucleotides encoding the same | |
DE69838104D1 (de) | C-terminale region des "agouti-related-transcript"-proteins (art) | |
WO2004035733A3 (en) | Isolated human hepsin/46 proteins, nucleic acid molecules encoding human hepsin/46 proteins, and uses thereof | |
ATE438660T1 (de) | Neue menschliche g-protein gekoppelten rezeptoren und dafür kodierende polynucleotide | |
WO2001094417A3 (en) | Novel human seven transmembrane proteins and polynucleotides encoding the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |